MARINUS PHARMACEUTICALS INC's ticker is and the CUSIP is 56854Q200.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $60,705 | +44.1% | 7,541 | +94.4% | 0.00% | +100.0% |
| Q2 2023 | $42,137 | +247764.7% | 3,880 | +54.9% | 0.00% | 0.0% |
| Q1 2023 | $17 | -82.8% | 2,505 | -89.9% | 0.00% | -75.0% |
| Q4 2022 | $99 | -99.1% | 24,735 | +1431.6% | 0.00% | – |
| Q3 2022 | $11,000 | -8.3% | 1,615 | -33.1% | 0.00% | – |
| Q2 2022 | $12,000 | -70.7% | 2,413 | -45.3% | 0.00% | – |
| Q1 2022 | $41,000 | +272.7% | 4,413 | +362.6% | 0.00% | – |
| Q4 2021 | $11,000 | -31.2% | 954 | -33.1% | 0.00% | – |
| Q3 2021 | $16,000 | -59.0% | 1,426 | -34.6% | 0.00% | -100.0% |
| Q2 2021 | $39,000 | +2.6% | 2,180 | -11.6% | 0.00% | 0.0% |
| Q1 2021 | $38,000 | -74.1% | 2,467 | -79.5% | 0.00% | -75.0% |
| Q4 2020 | $147,000 | -58.2% | 12,020 | -56.1% | 0.00% | 0.0% |
| Q3 2020 | $352,000 | – | 27,367 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Lion Point Capital, LP | 2,145,337 | $17,269,963 | 7.70% |
| Bleichroeder LP | 1,872,463 | $15,073,327 | 3.72% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 5,204,942 | $41,899,783 | 2.26% |
| Opaleye Management Inc. | 584,000 | $4,701,200 | 1.53% |
| Bain Capital Life Sciences Investors, LLC | 1,431,058 | $11,520,017 | 1.29% |
| Cormorant Asset Management, LP | 2,625,000 | $21,131,250 | 1.23% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 290,000 | $2,337,400 | 0.79% |
| Ikarian Capital, LLC | 746,069 | $6,005,856 | 0.72% |
| Eventide Asset Management | 4,529,997 | $36,466,476 | 0.66% |
| Altium Capital Management LP | 125,033 | $1,006,516 | 0.52% |